FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

758 letters match. Newest first.

  1. Evolution Pets LLC

    Evolution Pets marketed SeizureGuard Plus and Life Span Arthritis & Mobility as unapproved drugs for treating dog diseases.

    High risk
  2. Nutrition Strength Ltd.

    FDA warns Nutrition Strength Ltd. over unapproved dog seizure and blood-support supplements marketed as animal drugs.

    High risk
  3. Energetic Essences, LLC dba Pet Essences

    FDA warned Pet Essences that its Seizures formula is an unapproved new animal drug marketed to treat seizures in animals.

    High risk
  4. Veterinary Select Formula dba Allergic Pet

    FDA warns Allergic Pet over unapproved Nuroplex animal drugs marketed for seizures and epilepsy in dogs and cats.

    High risk
  5. Intermarket Industries Inc. dba Doc Ackerman Pet Products

    FDA warns Doc Ackerman Pet Products that its Epilepsy & Seizure Formula for dogs and cats is an unapproved new animal drug.

    High risk
  6. Guangzhou Sinocon Food Co., Ltd

    FDA warns Guangzhou Sinocon Food over food-safety violations in ready-to-eat Oat Beta Glucan powder, including pathogen hazards and inaccurate test certificates.

    High risk
  7. Bhargava Phytolab Private Limited

    FDA warns Bhargava Phytolab over drug and API current good manufacturing practice (CGMP) violations, including inadequate testing and sterility controls.

    High risk
  8. Viatris, Inc.

    FDA warns Viatris that its Indore, India, drug plant had unreliable quality data and weak investigations.

    High risk
  9. Sombra Cosmetics, Inc.

    FDA warned Sombra Cosmetics of OTC drug CGMP violations, including inadequate water controls and component testing.

    High risk
  10. Akron Formulations India Private Limited

    Akron Formulations India's over-the-counter drugs are adulterated due to manufacturing quality (CGMP) failures, including unqualified active ingredient (API) suppliers and inadequate microbial testing.

    High risk
  11. Brands International Corporation

    Brands International, a Canadian drug manufacturer, limited an FDA inspection and had manufacturing quality violations including mold contamination.

    High risk
  12. Shindler Distribution Inc. d/b/a VapoRush

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  13. Micro Orgo Chem

    Micro Orgo Chem in India failed CGMP for API drugs, including cleaning, process validation, stability and records.

    High risk
  14. WANABANA USA LLC

    WanaBana USA LLC failed to verify foreign supplier safety for lead-contaminated apple cinnamon puree pouches.

    High risk
  15. Han C. Phan, M.D.

    FDA warns clinical investigator Dr. Han C. Phan over failure to follow a drug study’s protocol for required tests.

    Medium
  16. Tova Industries, LLC

    Tova Industries was cited for missing required heat-and-acidity process controls and filings for acidified pancake syrups, vanilla flavorings, and soy sauces.

    High risk
  17. Adept Medical Ltd.

    Adept Medical Ltd. warning letter cites quality system and premarket violations for NeoZoline ventilation tubes, including unvalidated sterilization.

    High risk
  18. Barohup Inc.

    Barohup Inc. lacked foreign supplier verification for imported foods and kept importing enoki mushrooms after a Listeria finding.

    High risk
  19. Richard W. Foltin, Ph.D.

    FDA warned sponsor Dr. Richard W. Foltin for starting drug trials in people without an IND.

    High risk
  20. Unexo Lifesciences, Private Limited

    FDA warned Unexo Lifesciences over serious CGMP violations, including data integrity failures and torn batch records for U.S.-bound drugs.

    High risk
  21. Colgate-Palmolive/Tom's of Maine, Inc.

    FDA cited Tom's of Maine for CGMP failures after finding objectionable microbes in water and toothpaste and inadequate complaint handling.

    High risk
  22. Tianjin Darentang Jingwanhong Pharmaceutical Co., Ltd.

    FDA cited Tianjin Darentang Jingwanhong Pharmaceutical for limiting a drug inspection and manufacturing violations at its China plant.

    High risk
  23. Golden Shrimp Seafood Joint Stock Company

    Golden Shrimp Seafood's frozen yellowfin tuna had an inadequate seafood safety plan for controlling histamine.

    High risk
  24. Armstrong County Memorial Hospital

    FDA warns Armstrong County Memorial Hospital review board over missing procedures and inadequate meeting minutes for drug research.

    Medium
  25. Ardent Animal Health, LLC

    Ardent Animal Health marketed Acti-Stem Therapy and PureVet PRP as unapproved new animal drugs for dogs and cats.

    Medium
  26. Analytical Food Laboratories, Inc.

    FDA warned contract testing lab Analytical Food Laboratories after inspection found unvalidated drug test methods and weak quality oversight.

    High risk
  27. Future Best Trading Inc.

    FDA found Listeria in imported enoki mushrooms and cited Future Best Trading for lacking required supplier verification records.

    High risk
  28. Paso Real Produce LLC

    Paso Real Produce, a Texas importer, had no Foreign Supplier Verification Program at all for its imported avocados and limes — a repeat finding.

    Medium
  29. Blackfly Investments, LLC dba Molecular® Testing Labs

    Blackfly Investments dba Molecular Testing Labs sells an HIV dried blood spot self-collection kit without FDA marketing authorization.

    High risk
  30. Omni Lens Pvt. Ltd.

    FDA warns Omni Lens about CGMP failures and misbranding of ophthalmic OTC drugs made by unregistered contract manufacturers.

    High risk
  31. Pinnacle Transplant Technologies, LLC

    FDA warns Pinnacle Transplant Technologies over unapproved injectable amniotic products and sterility CGMP failures.

    High risk
  32. Stokes Healthcare Inc. dba Epicur Pharma

    Sterile compounding facility Epicur Pharma made drugs under insanitary conditions and with serious quality failures, FDA says.

    High risk
  33. Hemarus LLC

    Hemarus LLC failed blood-product manufacturing rules, including unapproved donor reinstatement and records signed when physician absent.

    High risk
  34. Bacalao Giraldo, S.L.U.

    FDA warns Spain's Bacalao Giraldo over inadequate HACCP controls for Clostridium botulinum in refrigerated and frozen desalted cod.

    High risk
  35. Bernardo Farms, LLC

    FDA: Bernardo Farms papaya farm in Pahoa, Hawaii, held papayas under insanitary conditions, with no field toilets and dirty tools.

    High risk
  36. Procesadora Marina De La Costa Oriental Del Lago C.A.

    FDA found HACCP violations at Procesadora Marina, a Venezuelan crabmeat processor; RTE crab may be unsafe.

    High risk
  37. MMC Healthcare Ltd.

    FDA warned MMC Healthcare Ltd. in Chennai that its drug products violate manufacturing rules, citing backdated records, weak computer controls, and unvalidated test methods.

    High risk
  38. Little Moon Essentials, LLC

    FDA warns Little Moon Essentials over CGMP failures and unapproved topical analgesic drugs made in Dania Beach, Florida.

    High risk
  39. Diamond Chemical Co., Inc.

    Diamond Chemical Co. in East Rutherford, NJ, made OTC hand sanitizers without required ingredient and finished-product testing or process validation.

    High risk
  40. Big Vegetarian Supply, Inc.

    FDA cites Big Vegetarian Supply for missing FSVP written assurances for three imported foods.

    Medium
  41. Aerosol and Liquid Packaging, Inc.

    FDA warns Aerosol and Liquid Packaging on CGMP failures and unapproved antiseptic spray claims.

    High risk
  42. Greco Gas, Inc.

    Greco Gas, Inc. released medical gases without identity or purity testing and without quality oversight.

    High risk
  43. Zydus Lifesciences Limited

    FDA warned Zydus Lifesciences over cross-contamination and glass particles in its injectable drugs, leading to recalls.

    High risk
  44. Orean Personal Care Ltd.

    FDA warned Orean Personal Care Ltd. that repeat manufacturing failures make its OTC drugs adulterated.

    High risk
  45. California Veterinary Supply

    FDA warned California Veterinary Supply for selling unapproved, unlisted antimicrobial fish and bird drugs online without FDA approval.

    High risk
  46. Regenerative Processing Plant, LLC

    FDA warns Regenerative Processing Plant over unapproved, misbranded Regener-Eyes eye drops and serious sterile manufacturing violations.

    High risk
  47. Wissner-Bosserhoff GmbH

    FDA warns German nursing bed maker Wissner-Bosserhoff over quality system failures and an unreported SafeControl handset correction.

    High risk
  48. Mother Stem Institute, Corp.

    FDA warns Mother Stem Institute over unapproved fat-derived SVF 'stem cell' biologic marketed for serious diseases.

    High risk
  49. Kaylaan LLC

    FDA warns Kaylaan LLC that its fluoride toothpaste tablets were made without release testing, raw material identity testing, and adequate CGMP controls.

    High risk
  50. 1 Stop Chicken Health Shop

    FDA warns 1 Stop Chicken Health Shop over selling unapproved animal drugs, including toltrazuril and enrofloxacin, for poultry and other birds.

    High risk